rapid-acting antidepressants

rapid-acting antidepressants

Advisory Panel Recommends FDA Approval of Esketamine , with New Mechanism to Treat Resistant Depression & Suicidal Thinking
On February 12th, an FDA advisory panel recommended overwhelmingly that the agency approve a drug called esketamine for the rapid... Read More
Seeking the Optimal Dose for Ketamine’s Short-Term Rapid Antidepressant Effects
Although many studies in recent years have provided evidence that ketamine, an anesthetic drug, can provide rapid relief to people... Read More
Researchers Discover That Fast-Acting Antidepressant Ketamine Engages the Body’s Opioid System
Alan F. Schatzberg, M.D. Stanford University School of Medicine Scientific Council Member (Joined 2005) 2005 Falcone Prizewinner for Outstanding Achievement... Read More
A Test of Ketamine in Adolescents With Resistant Depression
A small study of intravenous ketamine treatment for adolescents with treatment-resistant depression indicates that the drug may be an effective... Read More
Ketamine Rapidly Reduced Suicidal Thoughts in People with Depression
A single dose of ketamine, the anesthetic drug that has been found to have fast-acting antidepressant effects, can significantly reduce... Read More